MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05824364 | COMPLETED | NA
40 participants

Exercise aNd hEArt Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-05-20
Completion:
2025-09-30
Conditions
  • Heart Transplant
Interventions
  • OTHER
No Results Yet
NCT05773274 | RECRUITING | PHASE2
100 participants

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-01-12
Completion:
2029-04-30
Conditions
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Digestive System Neuroendocrine Tumor G2
  • Unresectable Digestive System Neuroendocrine Tumor G1
  • Unresectable Digestive System Neuroendocrine Tumor G2
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT05743478 | COMPLETED | NA
542 participants

Forging Hopeful Futures to Reduce Youth Violence

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-07-10
Completion:
2026-08-02
Conditions
  • Violence in Adolescence
  • Racism
  • Adolescent Behavior
  • Coping Skills
  • Communication, Social
  • Communication, Personal
  • Violence, Sexual
  • Violence, Non-accidental
  • Violence, Physical
  • Violence, Gender-Based
Interventions
  • BEHAVIORAL
No Results Yet
NCT05687123 | RECRUITING | PHASE1
24 participants

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-08-14
Completion:
2026-12-14
Conditions
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Pancreatic Neoplasm
  • Stage III Pancreatic Neuroendocrine Tumor AJCC v8
  • Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
  • Unresectable Pancreatic Neuroendocrine Tumor
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05677490 | RECRUITING | PHASE3
382 participants

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-01-31
Completion:
2028-11-08
Conditions
  • Advanced Esophageal Adenocarcinoma
  • Advanced Gastric Adenocarcinoma
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Unresectable Esophageal Adenocarcinoma
  • Unresectable Gastric Adenocarcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
NCT05617755 | ACTIVE_NOT_RECRUITING | PHASE1
19 participants

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2022-11-29
Completion:
2024-09-30
Conditions
  • Carcinoma, Ovarian Epithelial
  • Ovarian Neoplasms
  • Fallopian Tube Neoplasms
  • Peritoneal Neoplasms
  • Neoplasms, Glandular and Epithelial
  • Ovarian Diseases
  • Genital Neoplasm, Female
  • Abdominal Neoplasm
  • Recurrence
Interventions
  • BIOLOGICAL
No Results Yet
NCT05564390 | RECRUITING | PHASE2
2000 participants

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-06-18
Completion:
2029-05-15
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Acute Myeloid Leukemia, Myelodysplasia-Related
  • Myelodysplastic Syndrome
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT05564377 | RECRUITING | PHASE2
2900 participants

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-04-07
Completion:
2030-07-01
Conditions
  • Advanced Malignant Solid Neoplasm
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Locally Advanced Malignant Solid Neoplasm
  • Malignant Female Reproductive System Neoplasm
  • Metastatic HER2-Negative Breast Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Recurrent Endometrial Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Malignant Female Reproductive System Neoplasm
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Unresectable HER2-Negative Breast Carcinoma
  • Unresectable Malignant Solid Neoplasm
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page